Dr. Anand M. Irimpen, MD

Dr. Irimpen practices at Tulane Inpatient Rehab Center - Unit in New Orleans, Louisiana.

Dr. Irimpen's NPI, 1881700649, was assigned on August 22, 2006. Dr. Irimpen holds Louisiana license MD.09258R.

Dr. Irimpen's primary practice is Tulane Inpatient Rehab Center - Unit, at 1415 Tulane Ave, New Orleans, LA 70112.

Dr. Irimpen's primary practice is Tulane Inpatient Rehab Center - Unit in New Orleans, Louisiana. Dr. Irimpen is also affiliated with University Medical Center New Orleans. The medical group on file is Tulane Doctors. Dmand AI also links Dr. Irimpen to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Irimpen practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Irimpen's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Irimpen is licensed in Louisiana.

CMS data shows 94 Medicare services from Dr. Irimpen across 4 procedure codes in 2024, for 79 Medicare patients. Medicare paid $6,489 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. Irimpen in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 3.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Irimpen's median patient age at 67, with 39% women.

In 2024, Dr. Irimpen wrote 612 Medicare Part D claims for 95 patients. 92% of them were for generic drugs. CMS names the drug for 496 of them, across 12 drugs with 11 or more claims each, at $34,204 in total drug cost. In 2023, CMS named 616 claims across 18 drugs.

Dr. Irimpen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Irimpen, published from 2011 to 2025. 2018 was the busiest year, with 4. The most frequent topics are Myocardial Infarction, Cyclonic Storms and Fractional Flow Reserve, Myocardial. Dr. Irimpen has published most often in Am J Cardiol. Dr. Irimpen's most frequent co-authors are John C. Moscona, Morgan Jane Katz, MD and Paul Alex Katigbak, MD.

Dmand AI links Dr. Irimpen to 1 clinical trial. Conditions studied include Anemia, Iron-Deficiency and Anemia, Hypochromic.

CMS Open Payments shows 199 general payments to Dr. Irimpen from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $6,354.